Global Nuclear Receptor ROR Gamma Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Nuclear Receptor ROR Gamma Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Nuclear Receptor ROR Gamma Market Size Growth Rate by Product
  • 1.4.2 BBI-6000
  • 1.4.3 GRC-39815Action
  • 1.4.4 R&D Progress
  • 1.4.5 GSK-2981278
  • 1.4.6 IMU-366
  • 1.4.7 INV-17
  • 1.4.8 Others
• 1.5 Market by End User
  • 1.5.1 Global Nuclear Receptor ROR Gamma Market Size Growth Rate by End User
  • 1.5.2 Chronic Obstructive Pulmonary Disease
  • 1.5.3 Asthma
  • 1.5.4 Axial Spondyloarthritis
  • 1.5.5 Breast Cancer
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Nuclear Receptor ROR Gamma Market Size
  • 2.1.1 Global Nuclear Receptor ROR Gamma Revenue 2014-2025
  • 2.1.2 Global Nuclear Receptor ROR Gamma Sales 2014-2025
• 2.2 Nuclear Receptor ROR Gamma Growth Rate by Regions
  • 2.2.1 Global Nuclear Receptor ROR Gamma Sales by Regions
  • 2.2.2 Global Nuclear Receptor ROR Gamma Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Nuclear Receptor ROR Gamma Sales by Manufacturers
  • 3.1.1 Nuclear Receptor ROR Gamma Sales by Manufacturers
  • 3.1.2 Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers
  • 3.1.3 Global Nuclear Receptor ROR Gamma Market Concentration Ratio (CR5 and HHI)
• 3.2 Nuclear Receptor ROR Gamma Revenue by Manufacturers
  • 3.2.1 Nuclear Receptor ROR Gamma Revenue by Manufacturers (2014-2019)
  • 3.2.2 Nuclear Receptor ROR Gamma Revenue Share by Manufacturers (2014-2019)
• 3.3 Nuclear Receptor ROR Gamma Price by Manufacturers
• 3.4 Nuclear Receptor ROR Gamma Manufacturing Base Distribution, Product Types
  • 3.4.1 Nuclear Receptor ROR Gamma Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Nuclear Receptor ROR Gamma Product Type
  • 3.4.3 Date of International Manufacturers Enter into Nuclear Receptor ROR Gamma Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Nuclear Receptor ROR Gamma Sales by Product
• 4.2 Global Nuclear Receptor ROR Gamma Revenue by Product
• 4.3 Nuclear Receptor ROR Gamma Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Nuclear Receptor ROR Gamma Breakdown Data by End User

6 North America

• 6.1 North America Nuclear Receptor ROR Gamma by Countries
  • 6.1.1 North America Nuclear Receptor ROR Gamma Sales by Countries
  • 6.1.2 North America Nuclear Receptor ROR Gamma Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Nuclear Receptor ROR Gamma by Product
• 6.3 North America Nuclear Receptor ROR Gamma by End User

7 Europe

• 7.1 Europe Nuclear Receptor ROR Gamma by Countries
  • 7.1.1 Europe Nuclear Receptor ROR Gamma Sales by Countries
  • 7.1.2 Europe Nuclear Receptor ROR Gamma Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Nuclear Receptor ROR Gamma by Product
• 7.3 Europe Nuclear Receptor ROR Gamma by End User

8 Asia Pacific

• 8.1 Asia Pacific Nuclear Receptor ROR Gamma by Countries
  • 8.1.1 Asia Pacific Nuclear Receptor ROR Gamma Sales by Countries
  • 8.1.2 Asia Pacific Nuclear Receptor ROR Gamma Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Nuclear Receptor ROR Gamma by Product
• 8.3 Asia Pacific Nuclear Receptor ROR Gamma by End User

9 Central & South America

• 9.1 Central & South America Nuclear Receptor ROR Gamma by Countries
  • 9.1.1 Central & South America Nuclear Receptor ROR Gamma Sales by Countries
  • 9.1.2 Central & South America Nuclear Receptor ROR Gamma Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Nuclear Receptor ROR Gamma by Product
• 9.3 Central & South America Nuclear Receptor ROR Gamma by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Nuclear Receptor ROR Gamma by Countries
  • 10.1.1 Middle East and Africa Nuclear Receptor ROR Gamma Sales by Countries
  • 10.1.2 Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Nuclear Receptor ROR Gamma by Product
• 10.3 Middle East and Africa Nuclear Receptor ROR Gamma by End User

11 Company Profiles

• 11.1 Genfit SA
  • 11.1.1 Genfit SA Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Genfit SA Nuclear Receptor ROR Gamma Products Offered
  • 11.1.5 Genfit SA Recent Development
• 11.2 GlaxoSmithKline Plc
  • 11.2.1 GlaxoSmithKline Plc Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Products Offered
  • 11.2.5 GlaxoSmithKline Plc Recent Development
• 11.3 Aurigene Discovery Technologies Ltd
  • 11.3.1 Aurigene Discovery Technologies Ltd Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Products Offered
  • 11.3.5 Aurigene Discovery Technologies Ltd Recent Development
• 11.4 Beijing Hanmi Pharmaceutical Co Ltd
  • 11.4.1 Beijing Hanmi Pharmaceutical Co Ltd Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Products Offered
  • 11.4.5 Beijing Hanmi Pharmaceutical Co Ltd Recent Development
• 11.5 Biogen Inc
  • 11.5.1 Biogen Inc Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Biogen Inc Nuclear Receptor ROR Gamma Products Offered
  • 11.5.5 Biogen Inc Recent Development
• 11.6 AbbVie Inc
  • 11.6.1 AbbVie Inc Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 AbbVie Inc Nuclear Receptor ROR Gamma Products Offered
  • 11.6.5 AbbVie Inc Recent Development
• 11.7 Eurofins Advinus
  • 11.7.1 Eurofins Advinus Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Eurofins Advinus Nuclear Receptor ROR Gamma Products Offered
  • 11.7.5 Eurofins Advinus Recent Development
• 11.8 Brickell Biotech Inc
  • 11.8.1 Brickell Biotech Inc Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Brickell Biotech Inc Nuclear Receptor ROR Gamma Products Offered
  • 11.8.5 Brickell Biotech Inc Recent Development
• 11.9 Pfizer Inc
  • 11.9.1 Pfizer Inc Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Pfizer Inc Nuclear Receptor ROR Gamma Products Offered
  • 11.9.5 Pfizer Inc Recent Development
• 11.10 Phenex Pharmaceuticals AG
  • 11.10.1 Phenex Pharmaceuticals AG Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Products Offered
  • 11.10.5 Phenex Pharmaceuticals AG Recent Development
• 11.11 Reata Pharmaceuticals Inc
• 11.12 Bristol-Myers Squibb Company
• 11.13 Celgene Corp
• 11.14 Eli Lilly
• 11.15 Glenmark Pharmaceuticals Ltd
• 11.16 Lead Pharma Holding BV

12 Future Forecast

• 12.1 Nuclear Receptor ROR Gamma Market Forecast by Regions
  • 12.1.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Nuclear Receptor ROR Gamma Revenue Forecast by Regions 2019-2025
• 12.2 Nuclear Receptor ROR Gamma Market Forecast by Product
  • 12.2.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Product 2019-2025
  • 12.2.2 Global Nuclear Receptor ROR Gamma Revenue Forecast by Product 2019-2025
• 12.3 Nuclear Receptor ROR Gamma Market Forecast by End User
• 12.4 North America Nuclear Receptor ROR Gamma Forecast
• 12.5 Europe Nuclear Receptor ROR Gamma Forecast
• 12.6 Asia Pacific Nuclear Receptor ROR Gamma Forecast
• 12.7 Central & South America Nuclear Receptor ROR Gamma Forecast
• 12.8 Middle East and Africa Nuclear Receptor ROR Gamma Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Nuclear Receptor ROR Gamma Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details